Remarkably, MSI2 controlled pathways in LSCs and MLL1-HOXA9-MEIS1 leukemia programs were selectively enriched in GE independent LSC unique targets, which are expressed at the same or lower level in LSKs (Fig. 3k, Supplementary Data 3). The gene discussed is MSI2; the disease is leukemia.